Page Title
We live product development – transforming ground-breaking ideas into life-saving medication.

About Vakzine Projekt Management

VPM offers tailor-made consultancy and services based on in-depth experience in development of biopharmaceutical candidates. As a client, you will benefit from the experience of our team in translational project management. This enables you to bring your development projects into clinical trials faster, more cost-effectively and with a higher probability of success.

The company was established in 2002. Within the last decade, VPM has successfully managed and consulted the development of promising biopharmaceutical candidates, ranging from small molecules, recombinant proteins up to gene-modified live vaccines and ATMPs. VPM brought these products for its customers in the pharmaceutical industry, academic research and small biotechnology companies, from preclinical phase through clinical phases I-III.

News & Press

Press release on the results of a novel tuberculosis vaccine tested in a large phase III trial against severe respiratory infectious diseases

The course of respiratory infectious disease pandemics, will strongly depend on how quickly medications or specific vaccines against the pathogens are available. Researchers wanted to investigate in a phase III trial whether the vaccine candidate VPM1002 is also protective against an infection with the novel SARS-CoV-2. The large-scale study has been carried out at several hospitals in Germany and included older people that are susceptible to severe course of the disease. Read about the results here!

Career

Consulting and services

Speed up your development processes by using our expertise. We offer a comprehensive service portfolio covering all stages of pharmaceutical development.

Our Method

Translational project management from the laboratory bench to clinical development.

Scroll to Top